SCHEMBL4524422

SCHEMBL4524422

Cc1ccc(C(=O)NCCN(C)C)cc1-n1c(C)cc(OCc2ccccc2CNC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(OCCOC3CCCCO3)c2)c(Cl)c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 19/20 0.37
CDK8 P49336 4/20 0.37
RET P07949 3/20 0.37
PDGFRA P16234 3/20 0.37
GRK5 P34947 2/20 0.37
PRKX P51817 2/20 0.37
TYRO3 Q06418 2/20 0.37
NTRK2 Q16620 2/20 0.37
PRKAA1 Q13131 1/20 0.37
ROCK1 Q13464 1/20 0.37
TAOK1 Q7L7X3 1/20 0.37
GSK3A P49840 5/20 0.37
SRC P12931 3/20 0.37
AURKA O14965 1/20 0.36
DAPK3 O43293 1/20 0.36
JAK2 O60674 1/20 0.36
PRKD3 O94806 1/20 0.36
PAK4 O96013 1/20 0.36
ABL1 P00519 1/20 0.36
NTRK1 P04629 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4521340 0.95 MAPK14 (0.38) MAPK14CDK8RETPDGFRAGRK5
SCHEMBL4514157 0.95 MAPK14 (0.37) MAPK14CDK8RETPDGFRAGRK5
SCHEMBL4503425 0.93 MAPK14 (0.39) MAPK14AURKAMAPK12MAPK11
SCHEMBL4510417 0.92 MAPK14 (0.38) MAPK14GSK3ASRCAURKANTRK1
SCHEMBL13678591 0.89 MAPK14 (0.43) MAPK14CDK8RETPDGFRAGRK5
SCHEMBL13678568 0.89 MAPK14 (0.37) MAPK14AURKAMAPK12MAPK11MAPK9
SCHEMBL13678569 0.88 MAPK14 (0.36) MAPK14AURKANTRK1MAPK9
SCHEMBL4496970 0.88 MAPK14 (0.38) MAPK14RETABL1NTRK1FYN
SCHEMBL4497908 0.87 MAPK14 (0.38) MAPK14RETABL1NTRK1FYN
SCHEMBL4502277 0.85 MAPK14 (0.37) MAPK14RETABL1NTRK1FYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 US disclosed
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 US disclosed
EP-1987022-A1 PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES Pfizer Products Inc. (US) 2008-11-05 EP disclosed
WO-2007091176-A1 PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES PFIZER PRODUCTS INC. (US) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PDXK, UMPS, CDK2 MAPK14 117/4885CDK8 112/4885RET 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.